Table 1.
Clinical characterization of the patients
| Patients | Sex | Age* | Degree of severity* | DID (1: ) - Admission* | Group | Antifungal | Length of treatment (months)** | Length after treatment (months)** |
|---|---|---|---|---|---|---|---|---|
| P1 | M | 60 | Moderate | 16 | NTG | - | - | - |
| P2 | M | 53 | Severe | 128 | NTG | - | - | - |
| P3 | M | 59 | Moderate | 32 | NTG | - | - | - |
| P4 | F | 47 | Moderate | 64 | NTG | - | - | - |
| P5 | M | 44 | Moderate | 64 | NTG | - | - | - |
| P6 | M | 51 | Mild | NR | NTG | - | - | - |
| P7 | M | 64 | Moderate | 32 | NTG | - | - | - |
| P8 | M | 59 | Moderate | 32 | NTG | - | - | - |
| P9 | M | 52 | Moderate | 8 | NTG | - | - | - |
| P10 | M | 47 | Moderate | 32 | NTG | - | - | - |
| P11 | M | 37 | Moderate | 4 | NTG | - | - | - |
| P12 | M | 56 | Moderate | 16 | ACG | CMX | 25 | 28 |
| P13 | M | 39 | Severe | 64 | ACG | CMX | 173 | 37 |
| P14 | M | 60 | Mild | 16 | ACG | CMX | 97 | 45 |
| P15 | M | 56 | Moderate | 16 | ACG | CMX | 26 | 3 |
| P16 | M | 50 | Moderate | 512 | ACG | CMX | 53 | 62 |
| P17 | M | 42 | Moderate | 8 | ACG | CMX | 28 | 83 |
| P18 | M | 42 | Moderate | NR | ACG | ITC | 31 | 69 |
| P19 | M | 39 | Moderate | 2 | ACG | ITC | 32 | 27 |
| P20 | M | 40 | Severe | 128 | ACG | CMX/ITC | 33(CMX)/49(ITC) | 89 |
| P21 | M | 42 | Severe | 64 | ACG | CMX/ITC | 6(CMX)/131(ITC) | 53 |
| P22 | M | 51 | Severe | 128 | ACG | CMX/ITC | 44(CMX)/12(ITC) | 60 |
| P23 | M | 53 | Severe | 64 | ACG | CMX | 84 | 65 |
DID = double agar gel immunodiffusion test; NR = non-reagent; NTG = non-treated group; ACG = apparent cure group; CMX = cotrimoxazole; ITC = Itraconazole.
*Homogeneity (NTG x ACG):
Age: NTG =52 (37–64); ACG = 46 (39-60); p =0.18 (Mann–Whitney U test).
Degree of severity: NTG = ACG; p =0.31 (Fisher's exact test).
DID admission: NTG =32 (NR-1:128); ACG =32 (NR-1:512); p =0.66 (Mann-Whitney U test).
**Length of treatment (Mean ± SEM): 68 ± 14; Length after treatment (Mean ± SEM): 52 ± 7.